Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This was the second highest number of inspections per type of company made by the FDA in Kansas, equalling 33.3% of all inspections in the second quarter of 2024.
The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.
The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 1 | -- | -- |
| Blood and Blood Products | 1 | -- | -- |
| Compliance: Devices | -- | 1 | -- |
| Foodborne Biological Hazards | 7 | -- | -- |
| Human Cellular, Tissue, and Gene Therapies | 1 | -- | -- |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 11 | -- | -- |
| Postmarket Assurance: Devices | 1 | -- | -- |
Alerts Sign-up